Description

Buy Tafinlar (Dabrafenib/Trametinib) For Sale

Tafinlar is a type of targeted cancer drug that works by interfering with the growth and spread of cancer cells in the body.

Tafinlar is only used for the treatment of certain cancers that have a mutation in the BRAF gene.

Tafinlar works by targeting certain proteins made by the mutated BRAF gene that help cancer cells to grow. By blocking these proteins, Tafinlar stops or slows down the growth of the cancer cells.

What is Tafinlar used to treat?

Tafinlar is used alone or in combination with another medicine called trametinib (Mekinist) to treat certain types of cancer in people who have a BRAF gene mutation.

Tafinlar is for use in treating:

• melanoma (skin cancer) that cannot be treated with surgery or has spread to other parts of the body, or to prevent melanoma from coming back after surgery;
• non-small cell lung cancer that has spread to other parts of the body; or
• thyroid cancer (anaplastic thyroid cancer) that has spread to other parts of the body, and for which there are no other treatment options; or
• solid tumors (in adults and children 6 years and older) that cannot be removed with surgery, or have spread to other parts of the body, and that have gotten worse (progressed) and there are no other treatment options; or
• low-grade glioma (in children 1 year and older) that requires treatment with a medicine by mouth or injection (systemic therapy).

Your healthcare provider will perform a test for the BRAF V600E gene mutation to make sure this medicine is right for you.

It is not known if this medicine used alone is safe and effective in children.

It is not known if this medicine used in combination with trametinib is safe and effective in children younger than 1 year of age.

Warnings

Using Tafinlar with trametinib may increase your risk of developing a certain type of skin cancer. Ask your doctor about your specific risk. Tell your doctor if you notice any new skin symptoms.

Your healthcare provider should check your skin before you start treatment, and every two months while taking this medicine to look for any new skin cancers.

Your healthcare provider may continue to check your skin for six months after you stop treatment.

Before taking this medicine

You should not use Tafinlar if you are allergic to dabrafenib.

To make sure Tafinlar is safe for you, tell your doctor if you have ever had:

• heart problems;
• bleeding problems;
• liver or kidney problems;
• diabetes (dabrafenib may raise your blood sugar);
• eye problems (especially a problem with your retina); or
• a genetic enzyme deficiency called glucose-6-phosphate dehydrogenase (G6PD) deficiency.